Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Multiple Myeloma
,
Oncology
Elotuzumab-Based Triplet Regimen Stops Progression of High-Risk Smoldering Multiple Myeloma
Read More
FDA Approvals
The Hematology Pipeline Features New Immune Therapies, and Targeted Agents
Read More
Perspectives
Health Plans Must Monitor the Oncology Pipeline to Apply Appropriate Coverage Criteria, Maintain Treatment Value
Read More
FDA Approvals
CAR T-Cell Therapy Succeeds in Aggressive Lymphoma
Read More
Practice Management
Induction Therapy plus Autologous Stem-Cell Transplantation Still Cost-Effective for Newly Diagnosed Multiple Myeloma
Read More
Lymphoma
Obinutuzumab Prolongs Survival in Follicular Lymphoma
Read More
Letters to the Editor
Misunderstanding of Findings Related to a Recent Article
Read More
Cost, Access, and Delivery Challenge New Oncology Drug Options
Read More
Value-Based Oncology Management and Outcomes-Based Contracting
Read More
Cost-Savings Measures Will Dot the Oncology Landscape
Read More
95
96
97
98
99
100
101
Page 98 of 245
Results 971 - 980 of 2441
